Fiche société
University of California, San Diego
Traitements, essais et publications liés.
Traitements13programmes
Essais5liés
Publications3liées
SourceDBlocale
Traitements
13| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Blood Pressure Effects on Cognition and Brain Blood Flow in PDParkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs. | Parkinson | Non applicable | Traitement symptomatique | United States | À vérifier |
| Fluticasone 250 mg/salmeterol 50 mgThe primary aim of the pilot (SAPS) protocol is to determine the feasibility and utility of implementing the provisional design of the full scale TOM trial (e.g., the six month treatment period, the impact of the smoking cessation intervention). There is no active hypothesis for the Vanguard Protocol. | SEP | Phase 4 | À vérifier | United States | À vérifier |
| Intervening on Women's Health for Rural Young Cancer SurvivorsThe purpose of this pilot study is to evaluate the feasibility of a multi-component intervention to improve young female cancer survivors' engagement in goal-concordant reproductive health care. The investigators hypothesize that implementation of the intervention will result in increased young cancer survivors' engagement in goal-concordant reproductive health care. | Cancer | Non applicable | À vérifier | United States | À vérifier |
| IpratropiumAcute asthma produces greatly increased work of breathing and increased oxygen requirement secondary to bronchial narrowing and airway obstruction by inflammatory secretions. There is growing evidence that non-invasive ventilation can reverse these processes more efficiently than conventional asthma therapy. Surprisingly, there have not yet been any large scale prospective controlled studies to investigate this hypothesis, (either in adults or children). Consequently, the aim of this study is to determine if the use of non-invasive positive airway pressure, for children admitted to hospital with an acute exacerbation of asthma, reduces their work of breathing, need for adjunctive medications, and shortens the length of hospital stay, compared to current standard therapy. | SEP | Phase 4 | Immunomodulation | United States | À vérifier |
| IRE + intratumoral mitazalimab (CD40 antibody) injectionThis is a phase I study of an agonistic CD40 antibody (mitazalimab) injected intratumorally at the time of surgical IRE in patients with locally advanced pancreatic cancer. Intratumoral delivery has potential to be more effective than systemic (intravenous) delivery while decreasing the systemic side effects of immunotherapy. We hypothesize that local delivery of mitazalimab at the time of IRE in patients with locally advanced pancreatic cancer will be safe, augment the immune effects of IRE, and decrease the risk of recurrence. | Cancer | Phase 1 | United States | À vérifier | |
| Montelukast 10mgThe primary aim of the pilot (SAPS) protocol is to determine the feasibility and utility of implementing the provisional design of the full scale TOM trial (e.g., the six month treatment period, the impact of the smoking cessation intervention). There is no active hypothesis for the Vanguard Protocol. | SEP | Phase 4 | À vérifier | United States | À vérifier |
| NanoKnifeThis is a phase I study of an agonistic CD40 antibody (mitazalimab) injected intratumorally at the time of surgical IRE in patients with locally advanced pancreatic cancer. Intratumoral delivery has potential to be more effective than systemic (intravenous) delivery while decreasing the systemic side effects of immunotherapy. We hypothesize that local delivery of mitazalimab at the time of IRE in patients with locally advanced pancreatic cancer will be safe, augment the immune effects of IRE, and decrease the risk of recurrence. | Cancer | Phase 1 | United States | À vérifier | |
| Sham ComparatorThe goal of this clinical trial is to learn if a device which provides vagal nerve stimulation, applied to the tragus of the ear via an ear clip, can improve sleep in individuals recovering from stroke while they are treated in a rehabilitation hospital. The main questions this study aims to answer are: 1. Does using this device improve insomnia? 2. Does this device have any impact on the person's stroke severity, mobility, self-care, or ability to think? Researchers will compare this treatment to a sham (a look-alike device that will not deliver the stimulation). Participants will: * Complete questionnaires about insomnia and their ability to think * Use the device for 30 minutes every evening for at least 10 nights during their inpatient stay * Complete a log tracking their use of the device and any concerns | Accident vasculaire cérébral, Cancer, Épilepsie | Non applicable | À vérifier | United States | À vérifier |
| Theophylline 400 mgThe primary aim of the pilot (SAPS) protocol is to determine the feasibility and utility of implementing the provisional design of the full scale TOM trial (e.g., the six month treatment period, the impact of the smoking cessation intervention). There is no active hypothesis for the Vanguard Protocol. | SEP | Phase 4 | À vérifier | United States | À vérifier |
| Blood Pressure Effects on Cognition and Brain Blood Flow in PDParkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs. | Parkinson | Non applicable | Traitement symptomatique | United States | À vérifier |
| Intervening on Women's Health for Rural Young Cancer SurvivorsThe purpose of this pilot study is to evaluate the feasibility of a multi-component intervention to improve young female cancer survivors' engagement in goal-concordant reproductive health care. The investigators hypothesize that implementation of the intervention will result in increased young cancer survivors' engagement in goal-concordant reproductive health care. | Cancer | Non applicable | À vérifier | United States | À vérifier |
| IRE + intratumoral mitazalimab (CD40 antibody) injectionThis is a phase I study of an agonistic CD40 antibody (mitazalimab) injected intratumorally at the time of surgical IRE in patients with locally advanced pancreatic cancer. Intratumoral delivery has potential to be more effective than systemic (intravenous) delivery while decreasing the systemic side effects of immunotherapy. We hypothesize that local delivery of mitazalimab at the time of IRE in patients with locally advanced pancreatic cancer will be safe, augment the immune effects of IRE, and decrease the risk of recurrence. | Cancer | Phase 1 | United States | À vérifier | |
| Fluticasone 250 mg/salmeterol 50 mgThe primary aim of the pilot (SAPS) protocol is to determine the feasibility and utility of implementing the provisional design of the full scale TOM trial (e.g., the six month treatment period, the impact of the smoking cessation intervention). There is no active hypothesis for the Vanguard Protocol. | SEP | Phase 4 | À vérifier | United States | À vérifier |
Essais cliniques
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Cryoneurolysis | Cancer | Non applicable | NCT05444361 | Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy | ENROLLING_BY_INVITATION |
| Fluticasone 250 mg/salmeterol 50 mg | SEP | Phase 4 | NCT01696214 | SAPS — A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial | COMPLETED |
| IRE + intratumoral mitazalimab (CD40 antibody) injection | Cancer | Phase 1 | NCT06205849 | Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer | RECRUITING |
| Intervening on Women's Health for Rural Young Cancer Survivors | Cancer | Non applicable | NCT06664034 | Intervening on Women's Health for Rural Young Cancer Survivors | COMPLETED |
| Blood Pressure Effects on Cognition and Brain Blood Flow in PD | Parkinson | Non applicable | NCT05400174 | Blood Pressure Effects on Cognition and Brain Blood Flow in PD | RECRUITING |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Blood Pressure Effects on Cognition and Brain Blood Flow in PD | PRECISION study: impact of personalised cardiac anaesthesia and cerebral autoregulation on neurological outcomes in patients undergoing cardiac surgery - protocol for an international, multicentre, prospective cohort study. | BMJ open | ||
| Blood Pressure Effects on Cognition and Brain Blood Flow in PD | Tolerability and efficacy of full-body head-up tilt sleeping in Parkinson's disease and multiple system atrophy. | NPJ Parkinson's disease | ||
| Blood Pressure Effects on Cognition and Brain Blood Flow in PD | The effects of acute ketone monoester supplementation on brain insulin responsiveness and cognitive performance: Results of a randomized, double-blind, placebo-controlled crossover trial in older men with overweight. | Metabolism: clinical and experimental |